THE FAUCI FILES, Vol 3(6): Anthrax Vaccine Scam Unravels, Part III
January 20, 2000
"In the continuing unfolding story of the vaccines produced by
the Michigan Biological Products Institute, MBPI, there is some
disagreement within FDA and DoD as to who is responsible for
inspecting the anthrax vaccine line. The FDA has the authority
and responsibility for inspecting vaccine production."
"However according to the inspection report of the November 1996
FDA inspection at MBPI, the FDA did not cover the anthrax
vaccine inspection "since it comes under military inspection."
The DoD Health Affairs Office says the FDA inspects the anthrax
vaccine line, not the military. But according to Dr. Robert
Meyers, COO, the Army does inspect the anthrax vaccine line,
but the FDA has not relinquished authority to the DoD."
"The FDA inspectors have said that until recently, the anthrax
vaccine line was inspected only by the military. The concern
has been that if FDA has given an exception to DoD for the
anthrax vaccine, is DoD responsible for the safety and efficacy
of the vaccine?"
"Other reports have said that the DoD owns and maintains the
anthrax vaccine line. Who inspects the anthrax vaccines given
to veterinarians and meat handlers?"
The NIH/NIAID Direktor, Dr. Anthony "Mussolini" Fauci, is at the
center of the bureaucrat web of responsibility for ALL vaccines.
"MBPI makes the pertussis vaccine, rabies vaccine and
diphtheria, pertussis, tetanus vaccine components, as well as
plasma derivatives of albumin and immune globulin. In fact,
according to some reports, MBPI is the only source of immune
globulin."
Why is Dr. Fauci's administration plagued with corruption,
a fraudulent IL-2 patent by Fauci himself and unholy alliances
with the sleazy Pharmaceutical Fascists who represent and
reward "the favored few" at the expense of ALL others?
"Editor's Note: Assured Capital Return - to the Max!: In
September start-up company BioPort Corp. bought the only US
manufacturer of anthrax vaccine, the MBPI for a reported
$25 million. This included around $3.25M in cash and the
rest in IOU?s. Within three weeks, BioPort "won" a Pentagon
contract for $29 million to supply anthrax vaccine. Fortune
smile$ on the favored few."
Interestingly, this military-distributed digest does
NOT report the name of the primary perpetrator at BioPort who
is a partner in this company despite the fact that he never
invested as much as a single penny in the buyout with
his "partners":
ex-Chairman, Joint Chiefs of Staff, Admiral Crowe
The question remains:
Who was harmed or killed by the CONTAMINATED anthrax vaccine that
remains locked "in storage" due to "problems", the precise
nature of which have been subjected to the bureaucratic
conspiracy of silence?
Why has Fauci remained silent about a recent peer-reviewed
journal article that reported toxic levels of mercury
used as preservatives for vaccines under Fauci's tutelage?
Why has Dr. Anthony Fauci remained silent over the recent
journal article which reported that the very best technology
today CANNOT adequately detect the presence of Hepatitis C
virus in vaccines or in the blood supply?
Why does the NIH/NIAID stonewall and REFUSE to disclose
Fauci's personal FINANCIAL CONFLICTS OF INTEREST on the basis
that NIH "public servants" enjoy protection from public
Freedom of Information Act disclosure of ANY "financial information"?
Is Janet Reno, the U.S. Attorney General, so impaired by Parkinson's
Disease (and her "buddy system" with Fauci's boss Donna "Do Nothing"
Shalala) that she can't see what the hell is going on here?
Has the "soft money" corporate donations to our sold-out
"representatives" in Congress turned ALL of them into a
collective brothel for the large corporations?
As to our "Ethics President", William Jefferson Clinton, you
simply will not believe what his OUTRAGEOUS response has been
-- this, of course, will be covered in an upcoming edition of
THE FAUCI FILES.
Crooked Murdering Bastards !
fred
====
THE ASA NEWSLETTER
Applied Science and Analysis Inc.
ISSN 1057-9419
Editor: Col. Richard Price
http://www.asanltr.com/ASANews-98/anthrax.html
BIOSCOPE '98
by Dr. Barbara Price
Vaccines
Vaccines stimulate the immune system and elicit immune
responses. Ideally the response to the vaccine is the
development of antibodies that will attack the antigen and
prevent it from infecting the animal or human. Vaccine
development is still an art, although the understanding of the
science is increasing quickly. In retrospect, Edward Jenner and
mankind were fortunate that the cowpox vaccine worked to
prevent smallpox infections.
Our understanding is improving and our technology to develop
new vaccines is moving forward rapidly, but our understanding
is incomplete. The use of adjuvants to enhance vaccine potency
is still more in the realm of art, not science. Many adjuvants
are oily substances (often hydrocarbons such as paraffin and
squalene) that promote protein aggregation, which serves as a
slow releasing reserve when mixed with an antigen.
While adjuvants may enhance some vaccines, adjuvants can
themselves cause diseases. Human adjuvant disease was first
described by women who had injections with silicone, paraffin,
and other unknown compounds. It is a multi-symptom disease
characterized by rheumatoid arthritis, systemic sclerosis, and
other complaints of connective tissues.
Adding experimental adjuvants to existing licensed and approved
vaccines for humans is medical experimentation. Recent research
submitted to well known professional journals has implicated
squalene, which has been used as an adjuvant in animal
vaccines, in the blood sera of many patients with Gulf War
Syndrome. In this study, antibodies to squalene have been
found in almost all of the GWS patients and has been absent in
Gulf War veterans who do not have those symptoms. These same
squalene antibodies were present in a small group of people who
volunteered for vaccine trials in which squalene adjuvant was
used as a placebo. Squalene may act in a manner similar to
silicone in inducing autoimmune symptoms. And we need to pay
attention to this research.
Hopefully we will not find that our Gulf War veterans were an
unknowing part of a medical experiment that was not fully
thought out and was possibly illegal. Given the risk the US
perceived at the time of the Gulf War, whenIraq?s BW program
was suspected, but not proven, there were reasons to expedite
the vaccination program for those who might be exposed.
However, if adjuvants were added to licensed and approved
vaccines, those given the enhanced vaccines should have been
told.
In this context, perhaps the money spent by the government on
project management, adherence to federal regulations and
integrated management of timely FDA licensure for up to 18
vaccines to be used by U.S. troops faced with biological
warfare agents is not frivolous. Perhaps it is money wisely
spent and the contractual requirement for this adherence
reflects a concern within the US DoD's Biological Acquisition
Program that mistakes not be repeated. But if this is true, the
JVAP activities (DoD and contractor) need to be closely
monitored. The same people, perhaps in different positions, may
still be making decisions on our vaccine policies.
Anthrax Vaccination Update
In the continuing unfolding story of the vaccines produced by
the Michigan Biological Products Institute, MBPI, there is some
disagreement within FDA and DoD as to who is responsible for
inspecting the anthrax vaccine line. The FDA has the authority
and responsibility for inspecting vaccine production.
However according to the inspection report of the November 1996
FDA inspection at MBPI, the FDA did not cover the anthrax
vaccine inspection "since it comes under military inspection."
The DoD Health Affairs Office says the FDA inspects the anthrax
vaccine line, not the military. But according to Dr. Robert
Meyers, COO, the Army does inspect the anthrax vaccine line,
but the FDA has not relinquished authority to the DoD.
The FDA inspectors have said that until recently, the anthrax
vaccine line was inspected only by the military. The concern
has been that if FDA has given an exception to DoD for the
anthrax vaccine, is DoD responsible for the safety and efficacy
of the vaccine? And if so, the DoD cannot say the FDA has
approved the anthrax vaccine. How much distance is the FDA
putting between it and the anthrax vaccine? Other reports have
said that the DoD owns and maintains the anthrax vaccine line.
Who inspects the anthrax vaccines given to veterinarians and
meat handlers?
MBPI makes the pertussis vaccine, rabies vaccine and
diphtheria, pertussis, tetanus vaccine components, as well as
plasma derivatives of albumin and immune globulin. In fact,
according to some reports, MBPI is the only source of immune
globulin. According to the PRNewswire report announcing the $29
million dollar award to BioPort Corp. for anthrax vaccine
production, BioPort expects to earn most of its revenue from
the sale of the anthrax vaccines to DoD and from its plasma
fractionation services.
Antimicrobial Agent for Anthrax
University of Michigan and Novavax, Inc. of Columbia Maryland
have tested a chemical mixture, BCTP, against both anthrax and
the flu virus and found it effective. BCTP is an emulsion of
water, soybean oil, Triton X 100 and tri-n-butyl phosphate. The
BCTP killed most of the anthrax spores (Bacillus anthracis) in
a culture dish. BCTP also reduced the mouse death rate to 20%,
reduced skin lesions and swelling and helped to heal lesions on
mouse skin after it was applied to lesions infected with a
relative of anthrax, Bacillus cereus.
In separate experiments, laboratory mice stayed healthy after
BCTP, along with influenza A, was inserted into their nasal
passages. Between these studies and the development of a
vaccine based on protective antigen, it is possible that the
"old-fashioned" vaccine produced by BioPort will quickly become
obsolete.
Editor's Note: Assured Capital Return - to the Max!: In
September start-up company BioPort Corp. bought the only US
manufacturer of anthrax vaccine, the MBPI for a reported $25
million. This included around $3.25M in cash and the rest in
IOUs. Within three weeks, BioPort "won" a Pentagon contract
for $29 million to supply anthrax vaccine. Fortune smile$ on
the favored few.
For the Professional in Government and Industry with an
interest in Nuclear, Biological and Chemical Defense,
Disarmament and Verification; Emergency and Disaster Medical
Planning; Industrial Health and Safety; and Environmental
Protection
